QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, March 7, 2007, 27(10):2628-2635; doi:10.1523/JNEUROSCI.5053-06.2007

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (26) Citing Articles via Google Scholar Google Scholar Articles by Garzon, D. J. Articles by Fahnestock, M. Search for Related Content PubMed PubMed Citation Articles by Garzon, D. J. Articles by Fahnestock, M.

 Previous Article  |  Next Article 

Neurobiology of Disease
Oligomeric Amyloid Decreases Basal Levels of Brain-Derived Neurotrophic factor (BDNF) mRNA via Specific Downregulation of BDNF Transcripts IV and V in Differentiated Human Neuroblastoma Cells

Diego J. Garzon and Margaret Fahnestock

Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada L8N 3Z5

Correspondence should be addressed to Dr. Margaret Fahnestock, Department of Psychiatry and Behavioural Neurosciences, McMaster University, 1200 Main Street West, Hamilton, Ontario, Canada L8N 3Z5. Email: fahnest{at}mcmaster.ca

Alzheimer's disease (AD) is a senile dementia characterized by amyloid plaques, neurofibrillary tangles, and synaptic and cell loss. The "amyloid cascade" hypothesis suggests that amyloid-ß (Aß), the peptide deposited as amyloid plaques, is the primary insult in AD. However, debate continues over the mechanism of Aß toxicity and whether fibrillar or oligomeric Aß is the active species of the peptide that ultimately causes the synaptic loss and dementia associated with AD. Brain-derived neurotrophic factor (BDNF) is required for survival and function of cells compromised in AD. Decreased BDNF causes defects in long-term potentiation and memory and correlates with cognitive decline. We previously demonstrated that BDNF reduction occurs early in the course of AD, suggesting that decreased BDNF may promote neuronal dysfunction in AD. We also demonstrated that three of seven human BDNF transcripts are specifically downregulated in AD. What pathological feature(s) of AD leads to the decreased BDNF is unknown.

In this study, we administered both fibrillar and oligomeric conformations of Aß_1–42 to differentiated SH-SY5Y, a human neuroblastoma cell line, and measured both phosphorylated cAMP response element-binding protein (CREB), a regulator of BDNF transcription, and BDNF total mRNA. We found that oligomeric but not fibrillar preparations of Aß_1–42 significantly decrease both phosphorylated CREB and total BDNF mRNA. Furthermore, oligomeric Aß_1–42 decreases BDNF transcripts IV and V in these cells, demonstrating that Aß_1–42 downregulates the major BDNF transcript decreased in vivo in the AD brain. Thus, oligomeric Aß_1–42 could compromise neuronal function, causing memory loss and cognitive dysfunction by downregulation of BDNF in AD.

Key words: Alzheimer; neurotrophin; exons; real-time RT-PCR; cell culture; CREB

---

Received May 16, 2006; revised Jan. 26, 2007; accepted Feb. 2, 2007.

Correspondence should be addressed to Dr. Margaret Fahnestock, Department of Psychiatry and Behavioural Neurosciences, McMaster University, 1200 Main Street West, Hamilton, Ontario, Canada L8N 3Z5. Email: fahnest{at}mcmaster.ca

This article has been cited by other articles:

				M. Blurton-Jones, M. Kitazawa, H. Martinez-Coria, N. A. Castello, F.-J. Muller, J. F. Loring, T. R. Yamasaki, W. W. Poon, K. N. Green, and F. M. LaFerla Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease PNAS, August 11, 2009; 106(32): 13594 - 13599. [Abstract] [Full Text] [PDF]

				S. Peng, D. J. Garzon, M. Marchese, W. Klein, S. D. Ginsberg, B. M. Francis, H. T. J. Mount, E. J. Mufson, A. Salehi, and M. Fahnestock Decreased Brain-Derived Neurotrophic Factor Depends on Amyloid Aggregation State in Transgenic Mouse Models of Alzheimer's Disease J. Neurosci., July 22, 2009; 29(29): 9321 - 9329. [Abstract] [Full Text] [PDF]

				B. Gabriele and T. Enrico BDNF splice variants from the second promoter cluster support cell survival of differentiated neuroblastoma upon cytotoxic stress J. Cell Sci., January 1, 2009; 122(1): 36 - 43. [Abstract] [Full Text] [PDF]

				J. Gardiner, D. Barton, J. May Vanslambrouck, F. Braet, D. Hall, J. Marc, and R. Overall Defects in Tongue Papillae and Taste Sensation Indicate a Problem with Neurotrophic Support in Various Neurological Diseases Neuroscientist, June 1, 2008; 14(3): 240 - 250. [Abstract] [PDF]

				S. Petratos, Q.-X. Li, A. J. George, X. Hou, M. L. Kerr, S. E. Unabia, I. Hatzinisiriou, D. Maksel, M.-I. Aguilar, and D. H. Small The -amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism Brain, January 1, 2008; 131(1): 90 - 108. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help